Table: Hisamitsu -Q1 group results
Jul 7 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
May 31, 2017 May 31, 2016 Feb 28, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 36.08 38.15 147.00
(-5.4 pct) (-3.8 pct) (+0.7 pct)
Operating 5.09 5.74 24.10
(-11.4 pct) (+0.1 pct) (-8.4 pct)
Recurring 4.94 5.56 25.60
(-11.2 pct) (-1.8 pct) (-9.2 pct)
Net 3.67 4.53 18.50
(-18.9 pct) (+28.1 pct) (-9.3 pct)
EPS 43.92 yen 53.50 yen 221.12 yen
EPS Diluted 43.89 yen 53.48 yen
Ann Div 81.50 yen 82.00 yen
-Q2 div 40.50 yen 41.00 yen
-Q4 div 41.00 yen 41.00 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO